| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/02/2005 | WO2004041212A3 Apkc isoforms in nervous system disorders and cancer |
| 06/02/2005 | WO2004032855A3 Method for inhibiting angiogenesis with transforming growth factor-beta 3 inhibitors |
| 06/02/2005 | WO2004032614A3 Animal with modification of cytoplasmic dynein heavy chain 1 gene |
| 06/02/2005 | WO2004022745A3 Reversible, parallel and multitask cloning method and kit |
| 06/02/2005 | WO2004007691A3 Herbicide-resistant plants, and polynucleotides and methods for providing same |
| 06/02/2005 | WO2003090514A3 Adipocyte complement related protein zacrp14 |
| 06/02/2005 | WO2003087375A8 Cartilage differentiation regulating gene |
| 06/02/2005 | WO2003066667A3 Method and apparatus for performing submicroliter reactions with nucleic acids or proteins |
| 06/02/2005 | WO2003040161A3 Antisense modulation of activating transcription factor 3 expression |
| 06/02/2005 | WO2003013226A3 Non-transgenic herbicide resistant plants |
| 06/02/2005 | WO2002088320A3 Raav-vectored ribozyme compositions and methods for the treatment of retinal diseases |
| 06/02/2005 | US20050120418 Tomatoes having altered acid invertase activity due to non-transgenic alterations in acid invertase genes |
| 06/02/2005 | US20050120417 Expression cassette with promoter operably linked to polynucleotide or complement encoding polypeptide comprising a basic helix-loop-helix domain, and complements an Arabidopsis ind1mutant phenotype; genetic engineering |
| 06/02/2005 | US20050120416 Using vector transformation to generate corn seeds homozygous for transgene which conferring artificial nuclear male sterility (AMS) and heterozygous for a fertility-restoring gene linked to a "small seed" phenotype; for use as tool in propagating recombinant plants of preferential phenotypes; bioreactor |
| 06/02/2005 | US20050120415 Gene silencing |
| 06/02/2005 | US20050120414 Regulation of polynucleic acid activity and expression |
| 06/02/2005 | US20050120413 Expression vector comprising polynucleotide encoding aberrant adp-glucose pyrophosphorylase for use as tool in generating plants with increase yields in high heat environments |
| 06/02/2005 | US20050120412 Long day plants transformed with phytochrome characterized by altered flowering response to day length |
| 06/02/2005 | US20050120410 Nucleic acid sequences encoding the bos1 gene and promoter from arabidopisis thaliana and uses thereof |
| 06/02/2005 | US20050120409 Expression vector comprising nucleotide sequences coding hypersensitive response eliciting protein for use in generating disease, insect, drought and heat resistant plants; biological pest control |
| 06/02/2005 | US20050120408 Propagation of disease/herbicide/stress resistant plants; biological pest control |
| 06/02/2005 | US20050120407 Geranylgeranyl pyrophosphate synthases |
| 06/02/2005 | US20050120406 Nucleic acid sequences to proteins involved in isoprenoid synthesis |
| 06/02/2005 | US20050120405 Expression vector comprising nucleotide sequences coding threonine synthase for use in transformation and enhancing biosynthesis of lysine, leucine, threonine cysteine and isoleucine from aspartate in plants |
| 06/02/2005 | US20050120404 Cell division and proliferation preferred regulatory elements and uses thereof |
| 06/02/2005 | US20050120403 Inhibition of generative propagation in genetically modified herbicide resistant grasses |
| 06/02/2005 | US20050120402 Cloning methods and other methods of producing cells |
| 06/02/2005 | US20050120401 Method for targeting transcriptionally active loci |
| 06/02/2005 | US20050120400 Genetically engineered, galactosyltransferase deficient, pigs for use as source of organs, tissues and cells for xenotransplantation |
| 06/02/2005 | US20050120399 Reconstructing mammalian embryos by transfer of a donor nucleus to enucleated oocyte or one cell zygote for production of genetically identical individuals; uniformity of meat products and animal management |
| 06/02/2005 | US20050120397 Preventing spermatid differentiation via inhibition of caspase expression; gene expression inhibition; biological pest control; contraceptives; infertility treatment; male contraception |
| 06/02/2005 | US20050120395 Using vector comprising homing endonuclease gene (HEG) as tool in gnerating transgenic cells; heterologous gene transfer; improving exogenous gene expression |
| 06/02/2005 | US20050120394 System for achieving high expression of genes |
| 06/02/2005 | US20050120392 Using animal to identify modulators of blood coagulation; antithrombotic agents; identification and validation of platelet genes as targets for anti-thrombotic or thrombotic compounds |
| 06/02/2005 | US20050119472 GB virus C and methods of treating viral infections |
| 06/02/2005 | US20050119465 Glycosylated follicle stimulating hormone for use as therapeutic tool in treatment of reproductive disorders |
| 06/02/2005 | US20050119464 Protein |
| 06/02/2005 | US20050119462 Expression vectors and promoters for heterologous gene expression |
| 06/02/2005 | US20050119461 Which have affinity for oxazoline compounds; for treatment of glaucoma, dementia, mood disturbances, degenerative conditions, and neurodegenerative diseases |
| 06/02/2005 | US20050119459 Expression vector comprising nucleotide sequences coding late-gestation lung 1 (LGL-1) for use as tool in diagnosis prevention and treatment of respiratory system disorders |
| 06/02/2005 | US20050119458 Transport protein for use in identifying modulator for prevention and treatment of cell proliferative, skin and psychological disorders; anticonvulsants; insecticides; pesticides; anthelmintics |
| 06/02/2005 | US20050119457 Human proteins |
| 06/02/2005 | US20050119455 Polypeptide fusion comprising complementary determining regions for use as tool in immunotherapeutic and/or diagnostics; bioassay |
| 06/02/2005 | US20050119450 Biodegradable polyphosphoramidates for controlled release of bioactive substances |
| 06/02/2005 | US20050119306 Blocking transcription factor; culture product of transgenic fungi |
| 06/02/2005 | US20050119217 Methods and reagents for the treatment of proliferative diseases |
| 06/02/2005 | US20050119213 Vascular therapeutics |
| 06/02/2005 | US20050119212 Controlling gene expression; spinal cord injuries |
| 06/02/2005 | US20050119211 Moderators of gene expression; mixture of small nucleic acids |
| 06/02/2005 | US20050119210 Using genes encoding transmembrane protein as markers; targets for cancer therapy; drug screening |
| 06/02/2005 | US20050119209 Compositions and methods for the treatment and diagnosis of immune disorders |
| 06/02/2005 | US20050119208 Composition and method for treating lupus nephritis |
| 06/02/2005 | US20050119206 Cg8327, cg10823, cg18418, cg15862, cg3768, cg11447 and cg16750 homologous proteins involved in the regulation of energy homeostasis |
| 06/02/2005 | US20050119204 Osteopontin-related compositions and methods |
| 06/02/2005 | US20050119203 Smad7 inhibitors for the treatment of cns diseases |
| 06/02/2005 | US20050119202 Medicament to treat a fibrotic disease |
| 06/02/2005 | US20050119201 Inhibitor of dna methylation |
| 06/02/2005 | US20050119173 Novel potassium-dependent sodium-calcium exchanger |
| 06/02/2005 | US20050119171 Forsenic analysis; medical diagnosis; chromosome markers |
| 06/02/2005 | US20050119165 Vascular endothelial growth factor dimers |
| 06/02/2005 | US20050118730 Microchannel array component, microchannel array for recovering biomolecules, and method for recovering biomolecules |
| 06/02/2005 | US20050118719 Expression vector comprising C1-regulated promoter sequence for use as an enhanced tool in transfer of heterologous gene sequences into cells |
| 06/02/2005 | US20050118717 delivering to microtubules a microtubule binding substance, such as taxol, that is coupled to a herpes simplex virus 1 VP22 protein; may be used pharmaceutically to retard or arrest cell division of cells such as neoplastic cells or protozoal parasite cells in vitro or in vivo. |
| 06/02/2005 | US20050118710 Methods and compositions for defining gene function |
| 06/02/2005 | US20050118700 Immortalized avian cell lines |
| 06/02/2005 | US20050118699 Packaging complementation cell-line for sv-40 vectors |
| 06/02/2005 | US20050118696 Methods and means for modulating PGE synthase activity |
| 06/02/2005 | US20050118695 Alpha-amylase mutants |
| 06/02/2005 | US20050118689 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family |
| 06/02/2005 | US20050118687 Methods of synthesizing polynucleotide via reverse translation from protein and oligonucleotide used in this method |
| 06/02/2005 | US20050118685 Enhanced secretion of a polypeptide by a microorganism |
| 06/02/2005 | US20050118684 Recombinant antihemophilic factor for use as tool in treatment hemophilia |
| 06/02/2005 | US20050118682 Using transgenic animal to prepare osteoclastogenesis inhibitory factor (OCIF) for use in treatment of osteoporosis |
| 06/02/2005 | US20050118681 Transcription factor for use as regulatory tool in expression of musculin; treatment and prevention of myogenic cancers |
| 06/02/2005 | US20050118680 Human chemotactic protein |
| 06/02/2005 | US20050118679 Novel metalloproteinases |
| 06/02/2005 | US20050118677 CC chemokine receptor 5 DNA, new animal models and therapeutic agents for HIV infection |
| 06/02/2005 | US20050118672 Using peptide: N-Glycosidase F (PNGase-F) to generate glycopeptide with uniform glycosylation patterns |
| 06/02/2005 | US20050118668 Non-radioactive label fluorophore covalently bonded to a modified tyrosine residue |
| 06/02/2005 | US20050118659 Bacterial polypeptide for use in diagnosis, prevention and treatment of microbial infection |
| 06/02/2005 | US20050118656 Methods for diagnosis and treatment of epithelial-derived cancers |
| 06/02/2005 | US20050118649 Monitoring protein translocation into preferential cellular compartment via reporter expression of fluorescent protein fusion |
| 06/02/2005 | US20050118648 Methods and combinations for gene targeting by homologous recombination |
| 06/02/2005 | US20050118638 Using thyrotrophin (TSH) receptor as diagnostic tool in detection of autoimmune diseases; competive binding assay |
| 06/02/2005 | US20050118635 Using cytoskeletal membrane protein concentration as diagnostic indicator of cell proliferative disorders; antitumor agents |
| 06/02/2005 | US20050118634 Comparative genomic hybridization |
| 06/02/2005 | US20050118630 Nucleic acid sequences for detecting genetic markers for cancer in a biological sample |
| 06/02/2005 | US20050118628 Synthesizing polynucleotide sequences based on model generated sequences; bioinformatics; directed evolution of proteins |
| 06/02/2005 | US20050118626 Novel human collagen proteins and polynucleotides encoding the same |
| 06/02/2005 | US20050118621 Methods for labeling nucleotides, labeled nucleotides and useful intermediates |
| 06/02/2005 | US20050118614 Compositions and methods using eukaryotic Rad5 |
| 06/02/2005 | US20050118611 Thioaptamers enable discovery of physiological pathways and new therapeutic strategies |
| 06/02/2005 | US20050118610 Nucleotide sequences coding hydrolase for generating protein hydrolysates useful as flavour improving agents; food processing |
| 06/02/2005 | US20050118602 Using preferential primer pair and reverse transcription to generate complementary DNA library; genotyping; gene expression analysis |
| 06/02/2005 | US20050118601 Expression vector comprising nucleotide sequences coding nuclear receptor binding site and regulatory sequences for use as tool in identifying modulators or heme and cytochrome p450 biosynthesis |
| 06/02/2005 | US20050118600 Improved efficiency of cancer drugs based on gene expression; enzyme inhibitors; microarrays, probes, primers, animal models; PCR kits |
| 06/02/2005 | US20050118598 Polypeptides derived from fibrinogen; modified by cyclization; antiangiogenic; transgenic cells, animals |
| 06/02/2005 | US20050118597 Peptide II |
| 06/02/2005 | US20050118594 Enzymes |
| 06/02/2005 | US20050118592 Using allelic variation aristaless homeobox gene (ARX) as diagnostic tool in detection of convulsive and learning disorders |